Geode Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.2M | Buy |
|
|||||
|
2025
Q1 | $67.1M | Buy |
|
|||||
|
2024
Q4 | $55.6M | Buy |
|
|||||
|
2024
Q3 | $53M | Sell |
|
|||||
|
2024
Q2 | $41.8M | Buy |
|
|||||
|
2024
Q1 | $40M | Buy |
|
|||||
|
2023
Q4 | $37M | Buy |
|
|||||
|
2023
Q3 | $24.4M | Buy |
|
|||||
|
2023
Q2 | $25.9M | Buy |
|
|||||
|
2023
Q1 | $30.7M | Buy |
|
|||||
|
2022
Q4 | $32.8M | Buy |
|
|||||
|
2022
Q3 | $21.6M | Sell |
|
|||||
|
2022
Q2 | $11.9M | Sell |
|
|||||
|
2022
Q1 | $14.5M | Buy |
|
|||||
|
2021
Q4 | $11.7M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Buy |
|
|||||
|
2021
Q2 | $10.7M | Buy |
|
|||||
|
2021
Q1 | $8.14M | Buy |
|
|||||
|
2020
Q4 | $5.35M | Buy |
|
|||||
|
2020
Q3 | $4.6M | Sell |
|
|||||
|
2020
Q2 | $7.27M | Buy |
|
|||||
|
2020
Q1 | $5.93M | Buy |
|
|||||
|
2019
Q4 | $5.64M | Sell |
|
|||||
|
2019
Q3 | $8.09M | Buy |
|
|||||
|
2019
Q2 | $5.39M | Buy |
|
|||||
|
2019
Q1 | $5.85M | Buy |
|
|||||
|
2018
Q4 | $2.04M | Buy |
|
|||||
|
2018
Q3 | $3.64M | Buy |
|
|||||
|
2018
Q2 | $3M | Buy |
|
|||||
|
2018
Q1 | $2.04M | Buy |
|
|||||
|
2017
Q4 | $2.92M | Buy |
|
|||||
|
2017
Q3 | $1.58M | Buy |
|
|||||
|
2017
Q2 | $1.69M | Buy |
|
|||||
|
2017
Q1 | $902K | Buy |
|
|||||
|
2016
Q4 | $484K | Buy |
|
|||||
|
2016
Q3 | $501K | Buy |
|
|||||
|
2016
Q2 | $326K | Sell |
|
|||||
|
2016
Q1 | $561 | Buy |
|
|||||
|
2015
Q4 | $1.17M | Buy |
|
|||||
|
2015
Q3 | $1.41M | Buy |
|
|||||
|
2015
Q2 | $1.68M | Buy |
|
|||||
|
2015
Q1 | $1.53M | Buy |
|
|||||
|
2014
Q4 | $789K | Sell |
|
|||||
|
2014
Q3 | $937K | Sell |
|
|||||
|
2014
Q2 | $751K | Buy |
|
|||||
|
2014
Q1 | $392K | Buy |
|
|||||
|
2013
Q4 | $322K | Hold |
|
|||||
|
2013
Q3 | $505K | Hold |
|
|||||
|
2013
Q2 | $147K | Buy |
|